Showing results (601-610 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2026
Validating the European LeukemiaNet 2022 Guidelines in a Middle Eastern Acute Myeloid Leukemia Cohort: Correlation With Survival Outcomes and Comparison to ELN 2017Salem H Alshemmari, Ahmad AlSarraf, Reem Ameen, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 28, 2026
SOHO State of the Art Updates and Next Questions | Addressing the Transformative Questions in Aggressive B-Cell LymphomasGonca Ozcan, Mark Roschewski
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2024
SOHO State of the Art Updates and Next Questions | Diffuse Large B-Cell Lymphoma in Older Adults: A Comprehensive ReviewVarun Iyengar, Paul Hamlin, Pallawi Torka
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2024
Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical TrialsBruno Almeida Costa, Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 28, 2026
An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404Jonathon B Cohen, Craig A Portell, Mehdi Hamadani, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 28, 2026
Quad-Exposed/Refractory Multiple Myeloma: Patients Previously Treated With Anti-CD38, IMiDs, Proteasome Inhibitors, and BCMA-Targeted TherapiesMagdalena Olszewska-Szopa, David H Vesole, Artur Jurczyszyn
Clinical Lymphoma, Myeloma & Leukemia|May 29, 2026
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal FunctionLudek Pour, Sosana Delimpasi, Wojciech Legiec, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 10, 2026
Timing of Tyrosine Kinase Inhibitor Switching in Chronic Myeloid Leukemia: A Comparative Analysis of Early Versus Late StrategiesChidiebube Ugwu, Tarfa Verinumbe, Folajimi Atunde, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2026
Association Between Progression-Free Survival and Overall Survival in Mantle Cell Lymphoma: A Trial-level Surrogate Endpoint AnalysisAlexander M Gorzewski, Christina Raker, Victoria A Gill, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 20, 2026
Frontline Nilotinib Versus Dasatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Propensity Score Analysis Based on Agenzia Italiana del Farmaco Monitoring RegistriesMassimo Breccia, Simone Celant, Fabrizio Pane, et al.
Pageof 251